About 1-[(3S)-3,5-diphenyl-3,4-dihydropyrazol-2-yl]-2-morpholin-4-ium-4-ylethanone
1-[(3S)-3,5-diphenyl-3,4-dihydropyrazol-2-yl]-2-morpholin-4-ium-4-ylethanone (PubChem CID 6975212) has the molecular formula C21H24N3O2+
and a molecular weight of 350.44 g/mol. Its IUPAC name is 1-[(3S)-3,5-diphenyl-3,4-dihydropyrazol-2-yl]-2-morpholin-4-ium-4-ylethanone.
Analyze 1-[(3S)-3,5-diphenyl-3,4-dihydropyrazol-2-yl]-2-morpholin-4-ium-4-ylethanone with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 1-[(3S)-3,5-diphenyl-3,4-dihydropyrazol-2-yl]-2-morpholin-4-ium-4-ylethanone?
The IUPAC name of 1-[(3S)-3,5-diphenyl-3,4-dihydropyrazol-2-yl]-2-morpholin-4-ium-4-ylethanone (CID 6975212) is 1-[(3S)-3,5-diphenyl-3,4-dihydropyrazol-2-yl]-2-morpholin-4-ium-4-ylethanone.
What is the SMILES notation for 1-[(3S)-3,5-diphenyl-3,4-dihydropyrazol-2-yl]-2-morpholin-4-ium-4-ylethanone?
The canonical SMILES for 1-[(3S)-3,5-diphenyl-3,4-dihydropyrazol-2-yl]-2-morpholin-4-ium-4-ylethanone is O=C(C[NH+]1CCOCC1)N1N=C(c2ccccc2)C[C@H]1c1ccccc1.
What is the InChIKey of 1-[(3S)-3,5-diphenyl-3,4-dihydropyrazol-2-yl]-2-morpholin-4-ium-4-ylethanone?
The InChIKey is BRGRCFIEKXABRT-FQEVSTJZSA-O. The full InChI is InChI=1S/C21H23N3O2/c25-21(16-23-11-13-26-14-12-23)24-20(18-9-5-2-6-10-18)15-19(22-24)17-7-3-1-4-8-17/h1-10,20H,11-16H2/p+1/t20-/m0/s1.
What are the key properties of 1-[(3S)-3,5-diphenyl-3,4-dihydropyrazol-2-yl]-2-morpholin-4-ium-4-ylethanone?
1-[(3S)-3,5-diphenyl-3,4-dihydropyrazol-2-yl]-2-morpholin-4-ium-4-ylethanone has a molecular weight of 350.44 g/mol, XLogP of 1.28, 4 rotatable bonds, 1 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[(3S)-3,5-diphenyl-3,4-dihydropyrazol-2-yl]-2-morpholin-4-ium-4-ylethanone is sourced from PubChem (CID 6975212), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).